BEIJING,Nov. 18,2024-- Huahui Health,a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis,hepatology,and oncology,today announce
BANGKOK,Nov. 18,2024-- LINE SCALE UP was officially launched at the LINE Thailand Developer Conference 2024,an initiative from LINE Thailand designed to support high-potential startups in scaling thei
BAKU,Azerbaijan,Nov. 18,2024-- As COP29 kicked off under the theme "In Solidarity for a Green World",the event brought together global leaders,policymakers,and industry stakeholders from ne
CHENGDU,China,Nov. 18,2024-- In November 2024,C Ray Therapeutics (Chengdu) Co.,Ltd. (hereinafter referred to as "C Ray"),an innovative enterprise in the field of radiopharmaceuticals,announc
Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials,and 19.9% shares of common stock of Aclaris Therapeut
Informed by Industry Research,Comprehensive Programmes to Bridge Skills Gap through Reskilling and Upskilling
